Instant International
Written by: Xu Yi'an
2021-06-07 22:29
The last update date: 2021-06-07 22:29
Singapore’s expert committee said on June 7 that it continues to believe that the vaccine and the Modena vaccine are effective.
The conference said that the spread of messenger ribonucleic acid (mRNA) on the Internet is not true.
The "Pfizer Vaccine" was jointly developed by the American pharmaceutical company Pfizer and BioNTech; the "Modena Vaccine" was developed by the American pharmaceutical company Moderna.
They are all made with messenger ribonucleic acid (mRNA) technology.
The committee said that it has noticed the information circulating on social media that the mRNA vaccine is not effective against the new variant virus, and the inactivated vaccine can provide better protection in this regard. The Coxing vaccine developed by China (trade name is Corleford, CoronaVac) It is just one example.
A statement from the conference stated: "Our assessment is that based on continuous review of data and evidence, we still believe that the mRNA vaccine is safe and highly effective, and that it continues to display and protect against variant viruses of concern to the outside world."
The article stated that aside from the foreign community’s concerns about the Delta variant virus, emerging data indicate that the mRNA vaccine continues to be effective.
The Delta variant virus strain was first discovered in India in October 2020.
Singapore's new crown pneumonia epidemic: The picture shows on May 14, Singaporeans queuing to pay at a supermarket while complying with social distancing measures.
(AP)
The article also talked about inactivated vaccines: "Inactivated COVID-19 vaccines have variable protection, and there is no evidence to show that inactivated vaccines are more effective than mRNA vaccines against viruses of concern to the outside world."
Singapore will allow the private medical industry to introduce the new crown vaccine that is included in the emergency use list by the World Health Organization (WHO) through the Special Access Route (SAR).
Kexing Bio's vaccine has been included in the WHO list.
It will be vaccinated in Singapore without government subsidies.
The committee stated that "Kexing Vaccine has shown variable protection in many international studies." It said, "The most complete analysis of vaccines shows that it has an effective rate of 51%."
The article pointed out that Kexing vaccine still does not meet the requirements of the Health Sciences Authority of Singapore (Provisional Translation), and that further safety and quality data are still required to meet the requirements for evaluation.
The meeting also stated that the performance of Kexing vaccine against newer variant viruses such as the Delta variant virus and the product in the real world is still unknown.
[New Crown Vaccine] Can the unprecedented mRNA vaccine become the hope of rescue?
Fighting against variants, Chinese and Western competition, and pharmaceutical hegemony: mastering the overall situation of mRNA?
The epidemic situation in small towns in Indonesia and Brazil has stabilized.
The article mentions viruses of concern to the outside world, including the more contagious Delta variant virus.
It is the cause of the rapid spread of this wave of epidemic in Singapore.
China Kexing New Coronary Vaccine New Coronary Pneumonia